Making Viscoelastic Coagulation Monitoring Available To All Caregivers
Three Step Operation Allows Samples To Be Run Anywhere At Any Time With Results Within Minutes
Step 1
Simply add 300 microliters of whole blood patient sample directly from syringe to the sample collection well. No sample preparation or pipetting is required.
Step 2
Remove the sample cup and insert the cartridge into the VCM Analyzer.
Step 3
Review. Within Minutes of inserting the testing cartridge into the VCM, your results will begin to be displayed on the VCM touch screen.
About Entegrion
Our Leadership
The Entegrion Board of Directors is made of dedicated healthcare and leading executive professionals committed to enhancing patient outcomes through science and investments in research and development. To learn more about the Entegrion Board of Directors , please click below
Research And Engineering
Entegrion is a life sciences company dedicated to providing innovative solutions to improve clinicians’ ability to effectively manage hemostasis in patients. Our products bring about major changes to the critical pathways in the diagnosis and treatment of patient coagulopathies, enabling clinicians to rapidly and effectively advance care in both the hospital and field environments. From research and development through delivery to market, we partner with leading scientists, clinicians, and industry specialists to provide products that enable doctors to improve clinical outcomes for patients whose hemostatic state may be compromised. Entegrion’s products are designed to address the needs of clinicians in both civilian and military medicine. The U.S. Department of Defense has been a major funding partner for the advancement of our technologies, awarding more than $100 million in product development contracts since the company’s inception.
Experience Point of Care Results
Uncontrolled coagulopathy is a major cause of mortality in trauma, surgery, disease states and cardiac therapies. Routine point of care coagulation tests are limited in the information provided to assess and manage these, while, laboratory diagnostic tests offer more value at the cost of being more expensive and time delayed. With as many as 800 million PT/PTT coagulation tests requested worldwide in point of care testing, the recognized need for quality, easy to use and fast patient-side coagulation assessment is considered critical.
The VCM testing platform offers a cost effective, accurate, easy to use, and reliable global coagulation solution in just minutes. Entegrion’s VCM platform is changing hemostasis assessment, replacing traditional limited diagnostic testing methods with a more complete answer for diagnostics, monitoring and critical pathways management.